Paratek Pharmaceuticals

Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that advance our technology and strengthen Paratek. Our Vision To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.

radius health, inc.

We are a biopharmaceutical company dedicatedto transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

Costello Medical

At Costello Medical, we enjoy building lasting partnerships in the healthcare sector by providing exceptional service. Our vision is to be a leading global partner consistently striving for meaningful and outstanding contributions that improve people’s health and lives. Our experts support the healthcare sector in the analysis, interpretation, and communication of clinical and health economic data; our service offerings include evidence development, statistics, health economics, HTA, real-world evidence, market access, medical affairs, publications, and design. We are one of the most established independent agencies delivering medical communications and health economic services. We have grown organically since foundation in 2008 to a team of over 350 based in Cambridge, London, Manchester and Bristol in the UK and internationally in Singapore, China and the US. Our talented team has experience with a variety of leading pharmaceutical and device companies across an extensive range of therapy areas and geographies, including Europe, Asia Pacific, and North America. We are proud to have achieved a 3-star accreditation with Best Companies™ for a sixth consecutive year, and have achieved B Corp certification, showing that we meet the highest standards of verified social and environmental performance.

MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Please visit mannkindcorp.com to learn more.

Chiesi USA, Inc.

Chiesi USA, Inc., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties. Our employees take an entrepreneurial approach to meet the evolving needs of our customers. As a Public Benefit Corporation, Chiesi USA is committed to operating as a good corporate citizen; positively impacting communities in which we live and serve. Headquartered in Cary NC, we employ over 360 employees in the United States. Previously known as Cornerstone Therapeutics, the company was acquired by the Chiesi Group in 2014. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with more than 80 years of experience in the pharmaceutical industry. The Group employs more than 5,300 people in 27 affiliates worldwide, selling products in more than 80 countries. Chiesi is recognized as a top 50 company in terms of revenue and R&D. Careers at Chiesi USA Inc: Email: Chiesiusa.jobs@chiesi.com Business Development: Email: us.busdev@chiesi.com All other inquiries: Email: us.contact@chiesi.com